Guidance Notes and Best Practice Guides
CIPD: The Chartered Institute of Personnel and Development has named AXA PPP healthcare as its employee health & well-being online knowledge partner. In this role, AXA PPP healthcare’s industry experts will provide knowledgeable online content for CIPD HR professionals and front-line managers.
FSA: The Financial Services Authority has confirmed guidance that traded life policy investments (TLPIs) are high risk products that should not be promoted to the vast majority of retail investors in the UK.
The guidance is an interim measure – the FSA will shortly be consulting on new rules imposing significant restrictions on the promotion of non-mainstream investments, including TLPIs, to retail investors.
The guidance is an interim measure – the FSA will shortly be consulting on new rules imposing significant restrictions on the promotion of non-mainstream investments, including TLPIs, to retail investors.
OFT: The OFT has issued guidance on ‘misleading or otherwise undesirable trading names’ to businesses offering credit services or products.
Among other practices, the guidance is designed to stop businesses from misleading consumers about their commercial status by using names such as 'Helpline' or 'Debtline', or any name that implies a business is a charity or public service such as 'Citizens Advice Bureau' or 'Government'.
Among other practices, the guidance is designed to stop businesses from misleading consumers about their commercial status by using names such as 'Helpline' or 'Debtline', or any name that implies a business is a charity or public service such as 'Citizens Advice Bureau' or 'Government'.
NICE: Would you like to find high quality evidenced-based information more quickly and easily? Are you looking for a one-stop resource that collates information from all the best sources - such as Royal Colleges and the BNF?
NHS Evidence is a search engine that ‘provides free access to high quality clinical & non-clinical information, and is available to all GPs and practice workers’. You can use it to help save time & effort in finding the specialised information needed for making evidence-based, cost-effective decisions on patient care. A mobile version of the site is also available, making it simple to find information while on the move.
NICE: Patients with relapsing remitting multiple sclerosis can now be offered a pill that helps reduce the number of relapses, says NICE. Fingolimod (Gilenya) is the first pill-based medicine for the treatment of RRMS, and works by preventing white blood cells from attacking nerve cells in the brain & spinal cord.
BIS: A new online toolkit has been launched, which provides first-time employers with a step-by-step guide through their obligations when taking on a member of staff – See ‘In the News’ section for more information.
ICO: The Information Commissioner’s Office has published new guidance to help individuals securely delete personal information from their old devices – See ‘In the News’ section for more information.
